Published in J Hum Hypertens on December 25, 2008
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
A framework for public health action: the health impact pyramid. Am J Public Health (2010) 9.45
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ (2009) 6.23
Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78
Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ (2014) 5.55
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol (2014) 2.88
Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc (2010) 2.60
Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008. Circulation (2011) 2.54
Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open (2013) 2.40
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation (2013) 2.31
Diet and physical activity for the prevention of noncommunicable diseases in low- and middle-income countries: a systematic policy review. PLoS Med (2013) 1.79
Effective population-wide public health interventions to promote sodium reduction. CMAJ (2009) 1.56
Sodium intake from various time frames and incident hypertension among Chinese adults. Epidemiology (2013) 1.55
Target salt 2025: a global overview of national programs to encourage the food industry to reduce salt in foods. Nutrients (2014) 1.40
An evaluation of the effects of the Australian Food and Health Dialogue targets on the sodium content of bread, breakfast cereals and processed meats. Nutrients (2014) 1.34
Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc (2010) 1.28
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.21
The development of salty taste acceptance is related to dietary experience in human infants: a prospective study. Am J Clin Nutr (2012) 1.19
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2009) 1.13
Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study. PLoS One (2012) 1.11
Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation (2012) 1.08
To legislate or not to legislate? A comparison of the UK and South African approaches to the development and implementation of salt reduction programs. Nutrients (2014) 1.08
Aldosterone and arterial hypertension. Nat Rev Endocrinol (2009) 1.06
Reducing sodium in foods: the effect on flavor. Nutrients (2011) 1.06
Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ (2012) 1.02
Dietary sodium intake is associated with total fluid and sugar-sweetened beverage consumption in US children and adolescents aged 2-18 y: NHANES 2005-2008. Am J Clin Nutr (2013) 1.01
Facilitators and barriers to implementing a local policy to reduce sodium consumption in the County of Los Angeles government, California, 2009. Prev Chronic Dis (2011) 1.01
Socioeconomic inequality in salt intake in Britain 10 years after a national salt reduction programme. BMJ Open (2014) 1.01
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open (2013) 1.01
Population-wide sodium reduction: the bumpy road from evidence to policy. Ann Epidemiol (2012) 0.99
Dietary sodium, adiposity, and inflammation in healthy adolescents. Pediatrics (2014) 0.99
National approaches to monitoring population salt intake: a trade-off between accuracy and practicality? PLoS One (2012) 0.99
Dietary sodium intake: knowledge, attitudes and practices in Shandong Province, China, 2011. PLoS One (2013) 0.99
Salt restriction for the prevention of cardiovascular disease. Dtsch Arztebl Int (2010) 0.98
Preferences for salty and sweet tastes are elevated and related to each other during childhood. PLoS One (2014) 0.97
Blood pressure and particulate air pollution in schoolchildren of Lahore, Pakistan. BMC Public Health (2012) 0.96
The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion. Int J Behav Nutr Phys Act (2014) 0.96
High urinary sodium is associated with increased carotid intima-media thickness in normotensive overweight and obese adults. Am J Hypertens (2010) 0.94
Salinity in drinking water and the risk of (pre)eclampsia and gestational hypertension in coastal Bangladesh: a case-control study. PLoS One (2014) 0.94
Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru. Trials (2014) 0.94
Nutrition standards for away-from-home foods in the USA. Obes Rev (2012) 0.93
Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study. BMC Public Health (2014) 0.93
24h urinary sodium excretion and subsequent change in weight, waist circumference and body composition. PLoS One (2013) 0.92
Strategies to reduce dietary sodium intake. Curr Treat Options Cardiovasc Med (2012) 0.90
Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis (2013) 0.90
Assessing the average sodium content of prepacked foods with nutrition declarations: the importance of sales data. Nutrients (2014) 0.89
Healthy food procurement policies and their impact. Int J Environ Res Public Health (2014) 0.89
Flawed evidence should not derail sound policy: the case remains strong for population-wide sodium reduction. Am J Hypertens (2013) 0.89
Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother (2012) 0.88
Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon. Vasc Health Risk Manag (2013) 0.88
Patterns of sodium and potassium excretion and blood pressure in the African Diaspora. J Hum Hypertens (2011) 0.87
Alteration of subcapsular adrenocortical zonation in humans with aging: the progenitor zone predominates over the previously well-developed zona glomerulosa after 40 years of age. J Histochem Cytochem (2011) 0.87
Determinants of salt-restriction-spoon using behavior in China: application of the health belief model. PLoS One (2013) 0.87
Salt-restriction-spoon improved the salt intake among residents in China. PLoS One (2013) 0.87
Twenty-two-year population trends in sodium and potassium consumption: the Minnesota Heart Survey. J Am Heart Assoc (2013) 0.86
Assessing dietary quality of older Chinese people using the Chinese Diet Balance Index (DBI). PLoS One (2015) 0.86
Food sources of dietary sodium in the Japanese adult population: the international study of macro-/micronutrients and blood pressure (INTERMAP). Eur J Nutr (2016) 0.86
Shifting human salty taste preference: Potential opportunities and challenges in reducing dietary salt intake of Americans. Chemosens Percept (2015) 0.85
Optimisation modelling to assess cost of dietary improvement in remote Aboriginal Australia. PLoS One (2013) 0.85
How much salt do adults consume in climate vulnerable coastal Bangladesh? BMC Public Health (2014) 0.85
NaCl potentiates human fibrocyte differentiation. PLoS One (2012) 0.85
Sodium Consumption: An Individual's Choice? Int J Hypertens (2012) 0.84
TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation. PPAR Res (2014) 0.84
Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies. Eur J Clin Nutr (2011) 0.84
Dietary salt reduction and cardiovascular disease rates in India: a mathematical model. PLoS One (2012) 0.84
Health gain by salt reduction in europe: a modelling study. PLoS One (2015) 0.84
Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome. J Am Heart Assoc (2014) 0.84
Health Professional Advice and Adult Action to Reduce Sodium Intake. Am J Prev Med (2015) 0.83
FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats. PLoS One (2013) 0.83
Estimation of daily salt intake through a 24-hour urine collection in Pohang, Korea. J Korean Med Sci (2014) 0.82
Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture. Alzheimers Dement (2011) 0.82
Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension. Clin Exp Nephrol (2010) 0.81
Salt Accelerates Allograft Rejection through Serum- and Glucocorticoid-Regulated Kinase-1-Dependent Inhibition of Regulatory T Cells. J Am Soc Nephrol (2015) 0.81
Essential hypertension: an approach to its etiology and neurogenic pathophysiology. Int J Hypertens (2013) 0.81
Current levels of salt knowledge: a review of the literature. Nutrients (2014) 0.81
Changes in the Sodium Content of Australian Processed Foods between 1980 and 2013 Using Analytical Data. Nutrients (2017) 0.80
Design and baseline characteristics of the 10 Small Steps Study: a randomised controlled trial of an intervention to promote healthy behaviour using a lifestyle score and personalised feedback. BMC Public Health (2012) 0.80
Geographic and socioeconomic variation of sodium and potassium intake in Italy: results from the MINISAL-GIRCSI programme. BMJ Open (2015) 0.80
A high-salt diet further impairs age-associated declines in cognitive, behavioral, and cardiovascular functions in male Fischer brown Norway rats. J Nutr (2013) 0.80
Rural Latino caregivers' beliefs and behaviors around their children's salt consumption. Appetite (2014) 0.80
Nutritional impact of sodium reduction strategies on sodium intake from processed foods. Eur J Clin Nutr (2015) 0.80
Salt and hypertension: why is there still a debate? Kidney Int Suppl (2011) (2013) 0.79
Canadian initiatives to prevent hypertension by reducing dietary sodium. Nutrients (2011) 0.79
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study. BMC Nephrol (2012) 0.79
How can diet influence the risk of stroke? Int J Hypertens (2012) 0.79
Prospective care of heart failure in Japan: lessons from CHART studies. EPMA J (2011) 0.79
Estimating daily salt intake based on 24 h urinary sodium excretion in adults aged 18-69 years in Shandong, China. BMJ Open (2014) 0.79
The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional Study. Medicine (Baltimore) (2016) 0.79
Salt reduction in Australia: from advocacy to action. Cardiovasc Diagn Ther (2015) 0.79
Diet and polycystic kidney disease: A pilot intervention study. Clin Nutr (2016) 0.79
New approaches to modulating idiopathic pulmonary fibrosis. Curr Allergy Asthma Rep (2013) 0.79
Sodium intake in a cross-sectional, representative sample of New York City adults. Am J Public Health (2014) 0.79
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.79
Salt content in canteen and fast food meals in Denmark. Food Nutr Res (2010) 0.78
Brazilian solar saltworks - ancient uses and future possibilities. Aquat Biosyst (2012) 0.78
Effect of dietary salt on regulation of TGF-β in the kidney. Semin Nephrol (2012) 0.78
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Salt--more adverse effects. Lancet (1996) 2.17
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int (1980) 2.01
Diuretic-induced oedema. Lancet (1975) 1.84
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Fortnightly review: Beneficial effects of potassium. BMJ (2001) 1.59
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens (2003) 1.59
Platelet volume is not increased in essential hypertension. J Hum Hypertens (1994) 1.48
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39
Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet (1985) 1.38
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med (1994) 1.37
Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet (1986) 1.32
Sodium is more important than calcium in essential hypertension. Hypertension (1985) 1.26
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ (1990) 1.21
Structural skin capillary rarefaction in essential hypertension. Hypertension (1999) 1.21
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens (1985) 1.21
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. Br Med J (Clin Res Ed) (1982) 1.18
Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart (2003) 1.16
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension (1999) 1.15
Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension (1998) 1.15
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J (1979) 1.14
Hyperthyroidism and a parathyroid adenoma complicating lithium treatment. Lancet (1977) 1.12
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Br J Clin Pharmacol (1976) 1.08
Dietary salt and blood pressure. Lancet (1994) 1.08
Effect of salt intake on renal excretion of water in humans. Hypertension (2001) 1.04
Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) (1999) 1.04
Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens (1993) 1.04
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Effect of sodium intake on ability of human plasma to inhibit renal Na+-K+-adenosine triphosphatase in vitro. Lancet (1981) 1.02
Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens (1995) 1.01
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens (1988) 1.01
Diuretics and oedema: how to avoid rebound sodium retention. Lancet (1992) 1.00
A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p13.3. Clin Genet (1993) 1.00
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 0.99
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Physiology: cardiac peptides and the control of sodium excretion. Nature (1984) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med (1991) 0.96
Dietary sodium and potassium intake and blood pressure. Lancet (1983) 0.96
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens (1991) 0.95
Letter: Saralasin bolus test. Lancet (1975) 0.95
Sodium and blood pressure. Curr Opin Cardiol (2002) 0.95
The natriuretic hormone and essential hypertension. Lancet (1982) 0.94
Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension (1995) 0.94
Transepithelial sodium absorption is increased in people of African origin. Hypertension (2001) 0.94
Interested in developing a national programme to reduce dietary salt? J Hum Hypertens (2011) 0.93
The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J (1983) 0.93
Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension (2001) 0.92
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.92
Phenformin and metabolic acidosis. Lancet (1972) 0.92
Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand (2008) 0.91
Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens (2002) 0.91
Azathioprine for myasthenia gravis. Lancet (1972) 0.91
Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) (1992) 0.91
Letter: Hypotension during angiotensin blockade with saralasin. Lancet (1975) 0.90
Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens (2001) 0.90
Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man. Clin Sci (Lond) (1987) 0.90
Dietary sodium and blood pressure. JAMA (1996) 0.89
"Apparent" heart failure: a syndrome caused by renal artery stenoses. Heart (2000) 0.89
Does nifedipine reveal a functional abnormality of arteriolar smooth muscle cell in essential hypertension--the effect of altering sodium balance. J Cardiovasc Pharmacol (1985) 0.88
Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.88
Optimal dose of captopril in hypertension. Lancet (1982) 0.88
Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond) (1994) 0.88
Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney. Heart (1997) 0.87
Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem (1981) 0.87
Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome? Nephron (1982) 0.87
Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci (Lond) (1990) 0.87
High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant (1998) 0.87
Letter: Yersinia enterocolitica infection and thyroid disorders. Lancet (1975) 0.87
Reversal by verapamil of defect in sodium transport in leucocytes in essential hypertension. Br Med J (Clin Res Ed) (1984) 0.87
Potassium: more beneficial effects. Climacteric (2003) 0.87
The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. Clin Sci (Lond) (1980) 0.86
Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis. Clin Nephrol (1974) 0.86
Leucocyte cation transport in essential hypertension: its relation to the renin-angiotensin system. Br Med J (Clin Res Ed) (1981) 0.85
Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet (1982) 0.85
Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ (1994) 0.85
Angiotensin converting enzyme inhibitors in hypertension: potential problems. J Hypertens Suppl (1995) 0.85
Sodium intake and mortality. Lancet (1998) 0.85